Gimv exits biotech company Ablynx and releases resources for new investments in the biotech sector
Gimv and Gimv-managed Biotech Fonds Vlaanderen sold their remaining stake in the Belgian biotech company Ablynx yesterda…
Gimv and Gimv-managed Biotech Fonds Vlaanderen sold their remaining stake in the Belgian biotech company Ablynx yesterda…
Gimv and Gimv managed Biotech Fonds Vlaanderen invest in Complix, a biopharmaceutical company focused on the discovery a…
InteRNA Technologies B.V., a drug discovery and development company engaged in the development of microRNA-based therape…